Evidence map›Paper›PMID 20808815›Full record

ArticlePloS one2010

Systematic screening of Drosophila deficiency mutations for embryonic phenotypes and orphan receptor ligands.

Ashley P Wright, A Nicole Fox, Karl G Johnson, Kai Zinn

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ashley P WrightDivision of Biology, California Institute of Technology, Pasadena, California, United States of America.
A Nicole Fox
Karl G Johnson
Kai Zinn
California Institute of Technology · USPomona College · US

Funding

MOLECULAR GENETICS OF DROSOPHILA CNS DEVELOPMENTR01NS028182 · NINDS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI Engin Ozkan, KAI G ZINN · 1990 to 2026
$7.3M
Molecular Genetics of CNS DevelopmentR37NS028182 · NINDS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ZINN, KAI G · 2014 to 2020
$3.3M
Synaptic target selection in DrosophilaR01NS062821 · NINDS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ZINN, KAI G · 2009 to 2013
$2.1M
NINDS NIH HHS R01 NS028182NINDS NIH HHS R01 NS028182NINDS NIH HHS R01 NS062821NINDS NIH HHS R37 NS028182
6 · The paper itself

Abstract

This paper defines a collection of Drosophila deletion mutations (deficiencies) that can be systematically screened for embryonic phenotypes, orphan receptor ligands, and genes affecting protein localization. It reports the results of deficiency screens we have conducted that have revealed new axon guidance phenotypes in the central nervous system and neuromuscular system and permitted a quantitative assessment of the number of potential genes involved in regulating guidance of specific motor axon branches. Deficiency "kits" that cover the genome with a minimum number of lines have been established to facilitate gene mapping. These kits cannot be systematically analyzed for phenotypes, however, since embryos homozygous for many deficiencies in these kits fail to develop due to the loss of key gene products encoded within the deficiency. To create new kits that can be screened for phenotype, we have examined the development of the nervous system in embryos homozygous for more than 700 distinct deficiency mutations. A kit of approximately 400 deficiency lines for which homozygotes have a recognizable nervous system and intact body walls encompasses >80% of the genome. Here we show examples of screens of this kit for orphan receptor ligands and neuronal antigen expression. It can also be used to find genes involved in expression, patterning, and subcellular localization of any protein that can be visualized by antibody staining. A subset kit of 233 deficiency lines, for which homozygotes develop relatively normally to late stage 16, covers approximately 50% of the genome. We have screened it for axon guidance phenotypes, and we present examples of new phenotypes we have identified. The subset kit can be used to screen for phenotypes affecting all embryonic organs. In the future, these deficiency kits will allow Drosophila researchers to rapidly and efficiently execute genome-wide anatomical screens that require examination of individual embryos at high magnification.

Indexed as

LigandsPhenotypeSequence DeletionAnimalsAntigensAxonsCentral Nervous SystemDrosophila melanogasterGene Expression RegulationGenes, InsectHumansMotor NeuronsNeurogliaReceptors, Cell SurfaceTime FactorsAntigensLigandsReceptors, Cell Surface

Identifiers

PMID20808815
PMCPMC2924397
OpenAlexW1968766648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.